Introduction
Lymphocytic esophagitis (LyE) is a rare clinicopathological entity first described in 2006, recently considered a variant of eosinophilic esophagitis (EoE). Limited data exist regarding its clinical characteristics and natural history.
Aims & Methods
To characterize the clinical, epidemiological, endoscopic, and histological features of adult patients with a newly diagnosed LyE and to compare these features with those of a cohort of adult patients with a newly diagnosed EoE.
Retrospective observational case-control study conducted at University Hospital Vall d’Hebron (2015-2025). We identified consecutive adult patients (≥18 years) with newly diagnosed LyE (n=32) and EoE (n=84) with a minimum follow-up of 6 months. LyE diagnosis required esophageal dysfunction symptoms, ≥30 intraepithelial lymphocytes per high-power field (hpf) with CD3 immunohistochemistry, absence of granulocytes, and <15 eosinophils/hpf. EoE diagnosis required ≥15 eosinophils/hpf. Clinical, epidemiological, endoscopic, histological variables, and first-line treatment response were analyzed.
Results
LyE patients were significantly older than EoE patients (median 61 vs 41 years, p=0.0001), with 40.6% aged >70 years in LyE. Female predominance was observed in LyE (OR 3.62, 95% CI 1.6-8.1, p=0.0041) compared to male predominance in EoE. Smoking was more frequent in LyE (37.5% vs 9.5% in EoE, p=0.0008). Allergic comorbidities were less common in LyE (28.1% vs 71.4%, p=0.0001), while cardiovascular comorbidities predominated in this group. Dysphagia was the most common symptom in both groups, though food impaction was more frequent in EoE (69% vs 34.4%, p=0.0013). At the time of diagnosis, normal endoscopy was more common in LyE (43.7% vs 16.7%, p=0.0036), and among cases with abnormal findings, esophageal strictures were more prevalent in LyE (33.3% vs 10%, p=0.023). Median CD3+ lymphocyte count was 126/hpf (range 32-267), without significant difference between the two esophageal segments. Clinical response to proton pump inhibitor (PPIs) monotherapy was lower in LyE compared to EoE (59.3% vs 89.8%, p=0.0009), as was histological response (27.8% vs 63.3%, p=0.0082). Loss of follow-up was more common among patients with LyE than among patients with EoE (37.5% vs 4.8%, p<0.0001).
Conclusion
Our study represents the first Spanish case series on LyE, representing an emerging entity affecting predominantly older Caucasian women with distinct epidemiological, endoscopic, and histological features compared to EoE. The presence of strictures and tissue remodelling suggests a potentially stenosing chronic disease course. PPIs efficacy was significantly lower in LyE than EoE, supporting distinct pathophysiological mechanisms. Further studies are needed to characterize the natural history and identify more effective therapeutic strategies.